MCL coexpression mm9:2618
From FANTOM5_SSTAR
Phase1 CAGE Peaks
Short description | |
---|---|
Mm9::chr11:100711801..100711910,- | p1@Stat5b |
Mm9::chr1:64579555..64579570,+ | p3@Creb1 |
Mm9::chr2:22629802..22629818,+ | p5@Apbb1ip |
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0007595 | lactation | 0.000525453577807614 |
GO:0040018 | positive regulation of multicellular organism growth | 0.000541916708159128 |
GO:0045927 | positive regulation of growth | 0.000541916708159128 |
GO:0040014 | regulation of multicellular organism growth | 0.00165668885813224 |
GO:0035264 | multicellular organism growth | 0.0017728978103342 |
GO:0048609 | reproductive process in a multicellular organism | 0.0017728978103342 |
GO:0032504 | multicellular organism reproduction | 0.0017728978103342 |
GO:0040008 | regulation of growth | 0.00677155003102119 |
GO:0046544 | development of secondary male sexual characteristics | 0.00913772318388629 |
GO:0046543 | development of secondary female sexual characteristics | 0.00913772318388629 |
GO:0022414 | reproductive process | 0.00953896831623088 |
GO:0045136 | development of secondary sexual characteristics | 0.00978988128476555 |
GO:0001553 | luteinization | 0.00978988128476555 |
GO:0042448 | progesterone metabolic process | 0.00978988128476555 |
GO:0001779 | natural killer cell differentiation | 0.010749084587409 |
GO:0045647 | negative regulation of erythrocyte differentiation | 0.010749084587409 |
GO:0045931 | positive regulation of progression through mitotic cell cycle | 0.010749084587409 |
GO:0046887 | positive regulation of hormone secretion | 0.0120213437953102 |
GO:0045579 | positive regulation of B cell differentiation | 0.0120213437953102 |
GO:0045885 | positive regulation of survival gene product activity | 0.0137035810317932 |
GO:0019218 | regulation of steroid metabolic process | 0.0145333047197813 |
GO:0030856 | regulation of epithelial cell differentiation | 0.0145333047197813 |
GO:0042104 | positive regulation of activated T cell proliferation | 0.0147318040071788 |
GO:0045086 | positive regulation of interleukin-2 biosynthetic process | 0.0147318040071788 |
GO:0046006 | regulation of activated T cell proliferation | 0.0147318040071788 |
GO:0045577 | regulation of B cell differentiation | 0.0147318040071788 |
GO:0045646 | regulation of erythrocyte differentiation | 0.0147318040071788 |
GO:0000003 | reproduction | 0.0147318040071788 |
GO:0019915 | sequestering of lipid | 0.0147318040071788 |
GO:0051047 | positive regulation of secretion | 0.0147318040071788 |
GO:0043029 | T cell homeostasis | 0.0147318040071788 |
GO:0045884 | regulation of survival gene product activity | 0.015697718401954 |
GO:0045787 | positive regulation of progression through cell cycle | 0.0161165602808381 |
GO:0030101 | natural killer cell activation | 0.0161165602808381 |
GO:0045076 | regulation of interleukin-2 biosynthetic process | 0.0164887251820769 |
GO:0050798 | activated T cell proliferation | 0.0164887251820769 |
GO:0045621 | positive regulation of lymphocyte differentiation | 0.0180221371217239 |
GO:0042094 | interleukin-2 biosynthetic process | 0.0180221371217239 |
GO:0032623 | interleukin-2 production | 0.0182574285122074 |
GO:0008207 | C21-steroid hormone metabolic process | 0.0182574285122074 |
GO:0050729 | positive regulation of inflammatory response | 0.0182574285122074 |
GO:0031349 | positive regulation of defense response | 0.0182574285122074 |
GO:0021983 | pituitary gland development | 0.0182574285122074 |
GO:0019216 | regulation of lipid metabolic process | 0.0182574285122074 |
GO:0002260 | lymphocyte homeostasis | 0.0182574285122074 |
GO:0045638 | negative regulation of myeloid cell differentiation | 0.0182574285122074 |
GO:0065008 | regulation of biological quality | 0.0182574285122074 |
GO:0021536 | diencephalon development | 0.0182574285122074 |
GO:0046883 | regulation of hormone secretion | 0.0182574285122074 |
GO:0007346 | regulation of progression through mitotic cell cycle | 0.0182574285122074 |
GO:0030879 | mammary gland development | 0.0196872254762418 |
GO:0045619 | regulation of lymphocyte differentiation | 0.0201851833574128 |
GO:0050871 | positive regulation of B cell activation | 0.0213388829365318 |
GO:0001776 | leukocyte homeostasis | 0.0213388829365318 |
GO:0046661 | male sex differentiation | 0.0213388829365318 |
GO:0042102 | positive regulation of T cell proliferation | 0.0213388829365318 |
GO:0007259 | JAK-STAT cascade | 0.0213388829365318 |
GO:0048522 | positive regulation of cellular process | 0.0213388829365318 |
GO:0048872 | homeostasis of number of cells | 0.0213388829365318 |
GO:0031347 | regulation of defense response | 0.0213388829365318 |
GO:0050727 | regulation of inflammatory response | 0.0213388829365318 |
GO:0022601 | menstrual cycle phase | 0.0213388829365318 |
GO:0022602 | menstrual cycle process | 0.021723123468064 |
GO:0042108 | positive regulation of cytokine biosynthetic process | 0.0222005142636794 |
GO:0003700 | transcription factor activity | 0.0222005142636794 |
GO:0045637 | regulation of myeloid cell differentiation | 0.0222005142636794 |
GO:0008585 | female gonad development | 0.0222005142636794 |
GO:0030183 | B cell differentiation | 0.0222005142636794 |
GO:0032946 | positive regulation of mononuclear cell proliferation | 0.0222005142636794 |
GO:0046660 | female sex differentiation | 0.0222005142636794 |
GO:0046545 | development of primary female sexual characteristics | 0.0222005142636794 |
GO:0030855 | epithelial cell differentiation | 0.0222005142636794 |
GO:0050671 | positive regulation of lymphocyte proliferation | 0.0222005142636794 |
GO:0048518 | positive regulation of biological process | 0.0222005142636794 |
GO:0030218 | erythrocyte differentiation | 0.0222005142636794 |
GO:0050864 | regulation of B cell activation | 0.0222005142636794 |
GO:0045727 | positive regulation of translation | 0.0233654165316319 |
GO:0042698 | menstrual cycle | 0.0233654165316319 |
GO:0007565 | female pregnancy | 0.0233654165316319 |
GO:0046879 | hormone secretion | 0.0233654165316319 |
GO:0042129 | regulation of T cell proliferation | 0.0236168730883494 |
GO:0031328 | positive regulation of cellular biosynthetic process | 0.0236168730883494 |
GO:0050870 | positive regulation of T cell activation | 0.0236168730883494 |
GO:0048583 | regulation of response to stimulus | 0.023850553830615 |
GO:0019221 | cytokine and chemokine mediated signaling pathway | 0.023850553830615 |
GO:0030155 | regulation of cell adhesion | 0.023850553830615 |
GO:0035270 | endocrine system development | 0.0251440335065073 |
GO:0042035 | regulation of cytokine biosynthetic process | 0.0254182791441992 |
GO:0008406 | gonad development | 0.0254182791441992 |
GO:0051046 | regulation of secretion | 0.0254182791441992 |
GO:0007154 | cell communication | 0.0254182791441992 |
GO:0032944 | regulation of mononuclear cell proliferation | 0.0254182791441992 |
GO:0009891 | positive regulation of biosynthetic process | 0.0254182791441992 |
GO:0048608 | reproductive structure development | 0.0254182791441992 |
GO:0050670 | regulation of lymphocyte proliferation | 0.0254182791441992 |
GO:0042098 | T cell proliferation | 0.026099831366719 |
GO:0045137 | development of primary sexual characteristics | 0.0272352300156898 |
GO:0042089 | cytokine biosynthetic process | 0.0277800589229188 |
GO:0042107 | cytokine metabolic process | 0.0277800589229188 |
GO:0051251 | positive regulation of lymphocyte activation | 0.0277800589229188 |
GO:0050863 | regulation of T cell activation | 0.0284036963151058 |
GO:0048468 | cell development | 0.0286569061337543 |
GO:0009653 | anatomical structure morphogenesis | 0.0286569061337543 |
GO:0051247 | positive regulation of protein metabolic process | 0.0310734952340478 |
GO:0007548 | sex differentiation | 0.0311818288826871 |
GO:0032943 | mononuclear cell proliferation | 0.0311818288826871 |
GO:0048732 | gland development | 0.0311818288826871 |
GO:0046651 | lymphocyte proliferation | 0.0311818288826871 |
GO:0006916 | anti-apoptosis | 0.0325586519314431 |
GO:0042445 | hormone metabolic process | 0.0334980215175915 |
GO:0051249 | regulation of lymphocyte activation | 0.0340101291557644 |
GO:0042113 | B cell activation | 0.0340101291557644 |
GO:0045596 | negative regulation of cell differentiation | 0.0340101291557644 |
GO:0003006 | reproductive developmental process | 0.0340101291557644 |
GO:0050865 | regulation of cell activation | 0.0340101291557644 |
GO:0003001 | generation of a signal involved in cell-cell signaling | 0.0341071241282081 |
GO:0048513 | organ development | 0.035148398214911 |
GO:0030098 | lymphocyte differentiation | 0.035148398214911 |
GO:0030099 | myeloid cell differentiation | 0.035148398214911 |
GO:0001816 | cytokine production | 0.0374931362218485 |
GO:0030900 | forebrain development | 0.0375568027570968 |
GO:0051093 | negative regulation of developmental process | 0.0387304138435095 |
GO:0008361 | regulation of cell size | 0.0395171644779132 |
GO:0042110 | T cell activation | 0.043202129548393 |
GO:0002009 | morphogenesis of an epithelium | 0.044660203493905 |
GO:0002521 | leukocyte differentiation | 0.0457365477392694 |
GO:0006417 | regulation of translation | 0.0467953152711793 |
GO:0048731 | system development | 0.0488320331945464 |
GO:0031326 | regulation of cellular biosynthetic process | 0.0488320331945464 |
GO:0008202 | steroid metabolic process | 0.0488320331945464 |
Relative expression of the co-expression cluster over median <br>Analyst:
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>
Ontology term | p-value | n |
---|
Ontology term | p-value | n |
---|
Ontology term | p-value | n |
---|
TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
{{{tfbs_overrepresentation_jaspar}}} |